Tenoxicam

Tenoxicam

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	M01AC02 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only)
Pharmacokinetic data
Protein binding	High
Elimination half-life	30–140 hours
Identifiers
IUPAC name (3E)-3-[hydroxy(pyridin-2-ylamino)methylene] -2-methyl-2,3-dihydro-4H-thieno[2,3-e] [1,2]thiazin-4-one 1,1-dioxide
PubChem CID	5282194
ChemSpider	4471584 N
UNII	Z1R9N0A399
KEGG	D01767 Y
ChEBI	CHEBI:32192 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C13H11N3O4S2
Molar mass	337.376 g/mol
NY (what is this?)  (verify)

WikiDoc Resources for Tenoxicam
Articles
Most recent articles on Tenoxicam Most cited articles on Tenoxicam Review articles on Tenoxicam Articles on Tenoxicam in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tenoxicam Images of Tenoxicam Photos of Tenoxicam Podcasts & MP3s on Tenoxicam Videos on Tenoxicam
Evidence Based Medicine
Cochrane Collaboration on Tenoxicam Bandolier on Tenoxicam TRIP on Tenoxicam
Clinical Trials
Ongoing Trials on Tenoxicam at Clinical Trials.gov Trial results on Tenoxicam Clinical Trials on Tenoxicam at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tenoxicam NICE Guidance on Tenoxicam NHS PRODIGY Guidance FDA on Tenoxicam CDC on Tenoxicam
Books
Books on Tenoxicam
News
Tenoxicam in the news Be alerted to news on Tenoxicam News trends on Tenoxicam
Commentary
Blogs on Tenoxicam
Definitions
Definitions of Tenoxicam
Patient Resources / Community
Patient resources on Tenoxicam Discussion groups on Tenoxicam Patient Handouts on Tenoxicam Directions to Hospitals Treating Tenoxicam Risk calculators and risk factors for Tenoxicam
Healthcare Provider Resources
Symptoms of Tenoxicam Causes & Risk Factors for Tenoxicam Diagnostic studies for Tenoxicam Treatment of Tenoxicam
Continuing Medical Education (CME)
CME Programs on Tenoxicam
International
Tenoxicam en Espanol Tenoxicam en Francais
Business
Tenoxicam in the Marketplace Patents on Tenoxicam
Experimental / Informatics
List of terms related to Tenoxicam

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID). It is manufactured by Roche under the trade name Mobiflex. It is available in the United Kingdom as a prescription-only drug. Tenoxicam belongs to the class of NSAIDs known as oxicams. It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints).

Contraindications

The drug is contraindicated for patients who are seniors who have been given anesthesia or surgery; are at risk of increased bleeding or kidney failure; have an active inflammatory disease involving the stomach or intestine (like ulcerative colitis); have an active stomach or intestinal ulcer; have had an acute asthmatic attack, hives, rhinitis (inflammation of the inner lining of the nasal passage), or other allergic reactions caused by Aspirin or other nonsteroidal anti-inflammatory drugs (for example diclofenac, ibuprofen, indomethacin, naproxen).

See also

• Piroxicam